Dr Nicholas Sangala
-
My philosophy is built on three principles of personalised care.
First, I focus on personalised medical care—understanding your condition and ensuring it is managed in the best possible way using the most appropriate treatments.
Second, I believe in a personalised approach to how we work together as doctor and patient. Everyone is different, and taking the time to understand how each person thinks, asks questions, and makes decisions helps me support them in getting the best out of their health.
Third, I want to understand your life goals. Healthcare should not only treat a condition; it should help you live the life you want to live. By understanding what matters most to you, we can find an approach that optimises both your health and your quality of life.
His aim is simple:
“To help patients with kidney disease achieve the best possible health while living the life they want to live”
-
I am a British trained doctor, dual certified as a Nephrologist (Kidney Doctor) and Intensivist (Intensive Care). I completed my undergraduate medical training at the world-renowned King’s College London and went on to work in several centres of excellence, including King’s College Hospital, Guy’s and St Thomas’ Hospital in London and at the Wessex Kidney Centre - a large transplant centre in the UK. I have over 10 years experience as a Consultant Nephrologist (Kidney Doctor) in the UK.
-
I provide the full range of kidney care including all stages of Chronic Kidney Disease (CKD), hypertension, pre and post transplant, with deep expertise in haemodialysis, home haemodialysis and vasculitis.
I am an expert in Home Haemodialysis and have held a tenure as a Member of the Fresenius Medical Care European Advisory Board - Home Therapies (EMEA region), 2002-24.
-
I am a keen researcher with multiple publications:
Attitudes towards digital health technology for the care of people with chronic kidney disease: A technology acceptance model exploration.
Daphne Kaklamanou, Le Nguyen, Miznah Al-Abbadey, Nick Sangala, Robert Lewis. PLOS Digital Health. September 2024 DOI: 10.1371/journal.pdig.0000614Cardiac dysfunction in dialysing adults with end-stage kidney disease is associated with exercise intolerance: A pilot observational study.
Joe Antoun, Anthony I. Shepherd, Jo Corbett, Nicholas C. Sangala, Robert J. Lewis, Emma Lane, Zoe L. Saynor. Physiological Reports. September 2024 DOI: 10.14814/phy2.70050Prediction of hypotension during haemodialysis through data analytics and machine learning.
Shamsul Kabir Masum, Adrian Alan Hopgood, Robert Lewis, Nicholas Sangala. Journal of Kidney Care. 2024 September 2; 9(5) 215–225 DOI: 10.12968/jokc.2024.9.5.215Low-Volume Home Haemodialysis and In-Centre Haemodialysis: Comparison of Dialysis Adequacy in Obese Individuals.
Alalwan AA, Abou Trabeh A, Ahamed MMS, Jones S, Adjorlolo D, Lewis R, Sangala N.
Cureus. 2023 Feb 16;15(2):e35054. doi: 10.7759/cureus.35054Exploring patients' experiences of the impact of dialysis therapies on quality of life and wellbeing.
Joe Antoun, Daniel J. Brown, Daniel J. W. Jones, Beth G. Clarkson, Anthony I. Shepherd, Nicholas C. Sangala, Robert J. Lewis, Melitta A. McNarry, Kelly A. Mackintosh, Laura Mason, Jo Corbett, and Zoe L. Saynor.
Journal of Renal Care, 2022:1–9Understanding the Impact of Initial COVID-19 Restrictions on Physical Activity, Wellbeing and Quality of Life in Shielding Adults with End-Stage Renal Disease in the United Kingdom Dialysing at Home versus In-Centre and Their Experiences with Telemedicine.
Joe Antoun, Daniel J. Brown, Daniel J. W. Jones, Nicholas C. Sangala, Robert J. Lewis, Anthony I. Shepherd, Melitta A. McNarry, Kelly A. Mackintosh, Laura Mason, Jo Corbett and Zoe L. Saynor.
Int. J. Environ. Res. Public Health 2021, 18(6), 3144Remote Monitoring in Renal Medicine: Experience from a 6-Month Pilot during the COVID-19 Pandemic.
Sangala, N.C.; Lewis, R.J.; Gamble, J. J.
Kidney Care 2021, 6, 15–20Using more frequent haemodialysis to manage volume overload in dialysis patients with heart failure, obesity or pregnancy.
Nicholas Sangala, Maxence Ficheux, Hafedh Fessi, Natalie Borman and Allan Collins.
Nephrol Dial Transplant 2020 35: ii11–ii17Intra-dialytic hypotension: Identifying patients most at risk
Sangala N., Gangaram V., Atkins K., Elliot G., Lewis R. 2017.
Journal of Renal Care 43(2), 92–97Renal Replacement Therapy on the ICU.
N. Sangala and M. Ostermann.
Review article published online. www.renalmed.co.uk (2014)Progressive renal failure due to renal infiltration by BK polyoma virus and leukaemic cells: which is the culprit?
N. Sangala, A. Dewdney, N. Marley, T. Cranfield, G. Venkat Raman.
NDT Plus 2011 4(1): 46–48Combined ANCA-associated vasculitis and lupus syndrome following prolonged use of hydralazine – A timely reminder of an old foe.
N. Sangala, R. Lee, D. Goldsmith.
International Urology Nephrology. 2010; 42(2):503–6Early detection of CKD will reduce heart disease risk.
N. Sangala, D. Goldsmith.
Practitioner 2009; 253(1717):24–27
-
I have had the honour of speaking at a number of international forums
The use of water in an era of sustainability: can we be more efficient?
UK Kidney Week, 2024Haemodialysis in critically ill patients: techniques and strategies.
UK Dialysis Conference 2023Breaking the barriers to Home HD: The role of remote monitoring.
Dialysis Society Webinar, 2022How to get fluid right in hospitalised patients.
Annual Dialysis Conference UK, 2021Remote monitoring of home therapies patients.
Annual Dialysis Conference UK, 2021Vascular Access at the Limits: Button Holing PTFE Grafts,
Vascular Access Society Great Britain and Northern Ireland, 2019Achieving symptom free dialysis: is it all about fluid?
Annual Dialysis Conference UK, 2018